Together, mHLA-DR and ALC provide a more comprehensive view of immunoparalysis in sepsis, enhancing prognostic accuracy and possibly aiding in the identification of patients suitable for targeted immunotherapy (29, 31). This evidence concerns the gene ALLC and Sepsis.